Skip to main content
OpenTrials

Clinical trial condition

Advanced Biliary Tract Cancer

Explore clinical trials studying Advanced Biliary Tract Cancer. Study availability and eligibility vary by location and protocol.

13 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Advanced Biliary Tract Cancer trial results

Recruiting

A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer

NCT07265674

Conditions
Adenocarcinoma, Advanced Biliary Tract Cancer, Biliary Tract Cancer (BTC), +12 more
Locations
  • City of Hope (Site 107) Duarte, California, United States
  • University of California at Irvine (Site 101) Orange, California, United States
  • UCLA Medical Center (Site 117) Santa Monica, California, United States
  • Moffitt Cancer Center Magnolia Campus (Site 123) Tampa, Florida, United States
View all 18 locations
View Trial Details
Active, not recruiting

Lenvatinib Plus Paclitaxel for Patients With Advanced Biliary Tract Cancer Who Failed to Gemcitabine-based Treatment

NCT05170438

Conditions
Advanced Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +4 more
Locations
  • Chang Gung Memorial Hospital Kaohsiung City, Taiwan
  • Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung City, Taiwan
  • China Medical University Hospital Taichung, Taiwan
  • National Cheng Kung University Hospital Tainan, Taiwan
View Trial Details
Active, not recruiting

Combination Immunotherapy in Rare Cancers Under InvesTigation

NCT04969887

Conditions
Advanced Biliary Tract Cancer, Female Reproductive System Neoplasm, Female Urogenital Diseases, +14 more
Locations
  • Border Medical Oncology Unit Albury, New South Wales, Australia
  • Orange Health Service Orange, New South Wales, Australia
  • Blacktown Hospital Sydney, New South Wales, Australia
  • Calvary Mater Newcastle Waratah, New South Wales, Australia
View all 18 locations
View Trial Details
Active, not recruiting

NAPOLI-2: Fluorouracil, Leucovorin, and Nanoliposomal Irinotecan in Biliary Cancer

NCT04005339

Conditions
Advanced Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +6 more
Locations
  • Lombardi Comprehensive Cancer Center, Georgetown University Washington D.C., District of Columbia, United States
  • Indiana University Health Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States
  • Washington University School of Medicine- Siteman Cancer Center St Louis, Missouri, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
View Trial Details
Active, not recruiting

The Purpose of This Trial is to Determine if Regorafenib Plus Durvalumab (MEDI4736) is Safe and Effective in Treatment of Chemo Refractory Advanced Biliary Tract Cancers

NCT04781192

Conditions
Advanced Biliary Tract Cancer
Locations
  • University of Kansas Cancer Center - Overland Park Overland Park, Kansas, United States
  • The University of Kansas Medical Center Westwood, Kansas, United States
  • University of Kansas Cancer Center - North Kansas City, Missouri, United States
  • University of Kansas Cancer Center - Lee's Summit Lee's Summit, Missouri, United States
View Trial Details

Related conditions